Feb 13, 2020 / 12:30PM GMT
Jonas Jarvius - Q Linea AB - CEO and President
Thank you very much. With that, I'd like to welcome everyone to the fourth quarter report for Q Linea during 2019. We'll move through the presentation, and we look at slide number 2, which is our disclaimer slide in case we do any forward-looking statements.
If we then move into slide number 3, that's going to give a brief overview of Q Linea, in general. We are a company working with disruptive solutions for faster infectious disease diagnostics. The first product, as you can see, to right, it's ASTar instrument followed by consumables with a first focus on sepsis. I would also like to highlight on this Q4 call, we had a very important event after the end of the period that was announced late last night. That we have and now a global partnership with Thermo Fisher Scientific for the commercialization of ASTar. And I will come back to that at the end of my presentation. But I want to highlight that as a very key event in the company development.
If we then look at the company as such, we are located in Uppsala, Sweden, we have the
Q4 2019 Q Linea AB Earnings Call Transcript
Mar 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers